Xponance’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,091
| Closed | -$335K | – | 1209 |
|
|
2021
Q2 | $335K | Buy |
4,091
+1,166
| +40% | +$95.5K | 0.01% | 1045 |
|
|
2021
Q1 | $278K | Sell |
2,925
-453
| -13% | -$43.1K | 0.01% | 977 |
|
|
2020
Q4 | $210K | Sell |
3,378
-49
| -1% | -$3.05K | ﹤0.01% | 1029 |
|
|
2020
Q3 | $204K | Buy |
3,427
+54
| +2% | +$3.21K | 0.01% | 977 |
|
|
2020
Q2 | $235K | Buy |
+3,373
| New | +$235K | 0.01% | 911 |
|